Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) kicked off on June 22, 2022, at the price of $4.11, up 13.57% from the previous trading day. During the day, the shares moved up to $4.80 and dropped to $4.11 before settling in for the closing price of $4.20. Over the past 52 weeks, RYTM has traded in a range of $3.04-$21.74.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
While this was happening, its average annual earnings per share was recorded 53.80%. With a float of $50.24 million, this company’s outstanding shares have now reached $50.33 million.
Let’s look at the performance matrix of the company that is accounted for 140 employees. In terms of profitability, gross margin is +55.14, operating margin of -5391.85, and the pretax margin is -2207.10.
Rhythm Pharmaceuticals Inc. (RYTM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Rhythm Pharmaceuticals Inc. is 0.10%, while institutional ownership is 100.00%. The most recent insider transaction that took place on Mar 29, was worth 11,386. In this transaction Chief Accounting Officer of this company sold 1,023 shares at a rate of $11.13, taking the stock ownership to the 1,477 shares. Before that another transaction happened on Feb 15, when Company’s Chief Technical Officer sold 557 for $6.10, making the entire transaction worth $3,398. This insider now owns 1,006 shares in total.
Rhythm Pharmaceuticals Inc. (RYTM) Latest Financial update
In the latest quarterly report, which was put into the public domain on 3/30/2022, the organization reported -$1.05 earnings per share (EPS), lower than consensus estimate (set at -$1.01) by -$0.04. This company achieved a net margin of -2207.10 while generating a return on equity of -30.89. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.00% during the next five years compared to -4.40% drop over the previous five years of trading.
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) Trading Performance Indicators
Take a look at Rhythm Pharmaceuticals Inc.’s (RYTM) current performance indicators. Last quarter, stock had a quick ratio of 5.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 51.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.31, a number that is poised to hit -1.03 in the next quarter and is forecasted to reach -3.61 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc. (RYTM)
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) saw its 5-day average volume 4.43 million, a positive change from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 61.01%. Additionally, its Average True Range was 0.49.
During the past 100 days, Rhythm Pharmaceuticals Inc.’s (RYTM) raw stochastic average was set at 18.08%, which indicates a significant decrease from 85.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 141.20% in the past 14 days, which was higher than the 104.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.98, while its 200-day Moving Average is $9.05. Nevertheless, the first resistance level for the watch stands at $5.01 in the near term. At $5.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.70. If the price goes on to break the first support level at $4.32, it is likely to go to the next support level at $3.87. The third support level lies at $3.63 if the price breaches the second support level.
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) Key Stats
The company with the Market Capitalisation of 237.88 million has total of 50,394K Shares Outstanding. Its annual sales at the moment are 3,150 K in contrast with the sum of -69,610 K annual income. Company’s last quarter sales were recorded 1,500 K and last quarter income was -52,760 K.